HEADER    PROTEIN FIBRIL                          21-NOV-16   5MGQ              
TITLE     SOLUTION STRUCTURE OF OXIDIZED AND AMIDATED HUMAN IAPP (1-37), THE    
TITLE    2 DIABETES II PEPTIDE.                                                 
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: ISLET AMYLOID POLYPEPTIDE;                                 
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: AMYLIN,DIABETES-ASSOCIATED PEPTIDE,DAP,INSULINOMA AMYLOID   
COMPND   5 PEPTIDE;                                                             
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 OTHER_DETAILS: RESIDUE NAME "TYC" REFERS TO AMIDATION OF C-TERMINAL  
COMPND   8 TYR.                                                                 
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: IAPP;                                                          
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);                       
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 469008                                      
KEYWDS    RECOMBINANT HUMAN IAPP, TYPE II DIABETES, PROTEIN FIBRIL              
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    D.C.RODRIGUEZ CAMARGO,K.TRIPSIANES,B.REIF                             
REVDAT   5   14-JUN-23 5MGQ    1       REMARK SEQRES                            
REVDAT   4   08-MAY-19 5MGQ    1       REMARK                                   
REVDAT   3   17-JAN-18 5MGQ    1       COMPND                                   
REVDAT   2   06-SEP-17 5MGQ    1       REMARK                                   
REVDAT   1   29-MAR-17 5MGQ    0                                                
JRNL        AUTH   D.C.RODRIGUEZ CAMARGO,K.TRIPSIANES,K.BUDAY,A.FRANKO,C.GOBL,  
JRNL        AUTH 2 C.HARTLMULLER,R.SARKAR,M.AICHLER,G.METTENLEITER,M.SCHULZ,    
JRNL        AUTH 3 A.BODDRICH,C.ERCK,H.MARTENS,A.K.WALCH,T.MADL,E.E.WANKER,     
JRNL        AUTH 4 M.CONRAD,M.H.DE ANGELIS,B.REIF                               
JRNL        TITL   THE REDOX ENVIRONMENT TRIGGERS CONFORMATIONAL CHANGES AND    
JRNL        TITL 2 AGGREGATION OF HIAPP IN TYPE II DIABETES.                    
JRNL        REF    SCI REP                       V.   7 44041 2017              
JRNL        REFN                   ESSN 2045-2322                               
JRNL        PMID   28287098                                                     
JRNL        DOI    10.1038/SREP44041                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS                                                  
REMARK   3   AUTHORS     : BRUNGER A. T. ET.AL.                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 5MGQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-NOV-16.                  
REMARK 100 THE DEPOSITION ID IS D_1200002414.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 278                                
REMARK 210  PH                             : 5.3                                
REMARK 210  IONIC STRENGTH                 : 0                                  
REMARK 210  PRESSURE                       : 1 ATM                              
REMARK 210  SAMPLE CONTENTS                : 150 UM [U-99% 13C; U-99% 15N]      
REMARK 210                                   ISLET AMYLOID POLYPEPTIDE (IAPP    
REMARK 210                                   OR AMYLIN), 90% H2O/10% D2O        
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D 1H-15N HSQC; 2D 1H-13C HSQC;    
REMARK 210                                   3D HNCACB; 3D CBCA(CO)NH; 3D       
REMARK 210                                   HCCH-TOCSY; 3D 1H-15N NOESY        
REMARK 210  SPECTROMETER FIELD STRENGTH    : 500 MHZ; 600 MHZ; 750 MHZ          
REMARK 210  SPECTROMETER MODEL             : AVANCE                             
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : SPARKY, TOPSPIN, CYANA             
REMARK 210   METHOD USED                   : MOLECULAR DYNAMICS                 
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 200                                
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 200 ANGSTROM**2                           
REMARK 350 SURFACE AREA OF THE COMPLEX: 3260 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL                          
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 ASN A   3       20.80   -147.50                                   
REMARK 500  1 HIS A  18      -38.60   -143.89                                   
REMARK 500  1 ASN A  22      -35.15   -138.17                                   
REMARK 500  1 PHE A  23       88.59    -45.16                                   
REMARK 500  1 SER A  29      -30.23     67.77                                   
REMARK 500  1 SER A  34       73.40     55.38                                   
REMARK 500  2 SER A  29      -13.44     72.86                                   
REMARK 500  3 PHE A  23       96.61    -53.82                                   
REMARK 500  4 SER A  29      -10.63     68.44                                   
REMARK 500  5 HIS A  18       15.22   -142.51                                   
REMARK 500  5 SER A  20        6.62    -65.98                                   
REMARK 500  5 ASN A  22      -33.88   -139.47                                   
REMARK 500  5 PHE A  23       93.08    -47.75                                   
REMARK 500  5 THR A  30        0.42     54.44                                   
REMARK 500  6 ASN A   3       18.37   -144.75                                   
REMARK 500  6 CYS A   7      -38.49   -133.14                                   
REMARK 500  6 ASN A  22      -39.02   -136.85                                   
REMARK 500  6 PHE A  23      102.05    -56.94                                   
REMARK 500  6 ASN A  35       90.39     59.26                                   
REMARK 500  7 ASN A   3       20.26   -140.57                                   
REMARK 500  7 HIS A  18      -51.74   -139.99                                   
REMARK 500  7 SER A  29      -33.72     66.08                                   
REMARK 500  7 THR A  30       29.55    -74.65                                   
REMARK 500  8 CYS A   7      -39.15   -130.34                                   
REMARK 500  8 ASN A  22      -36.25   -134.36                                   
REMARK 500  8 PHE A  23       99.50    -55.14                                   
REMARK 500  8 ASN A  35      130.00   -171.46                                   
REMARK 500  9 HIS A  18       29.24   -158.59                                   
REMARK 500  9 ASN A  22      -36.67   -132.66                                   
REMARK 500  9 PHE A  23       83.65    -48.91                                   
REMARK 500 10 ASN A   3       25.33   -154.27                                   
REMARK 500 10 CYS A   7      -39.28   -130.64                                   
REMARK 500 10 HIS A  18       16.69   -159.12                                   
REMARK 500 10 SER A  20       12.19    -65.35                                   
REMARK 500 10 ASN A  22      -38.48   -137.81                                   
REMARK 500 10 PHE A  23       93.12    -47.52                                   
REMARK 500 10 ASN A  31       39.56   -140.31                                   
REMARK 500 11 SER A  20        1.94    -68.35                                   
REMARK 500 11 ASN A  22      -50.63   -128.75                                   
REMARK 500 11 PHE A  23       93.45    -54.13                                   
REMARK 500 11 ASN A  35      -34.95   -146.72                                   
REMARK 500 12 ASN A   3       21.71   -145.90                                   
REMARK 500 12 SER A  20       -7.41    -56.48                                   
REMARK 500 12 ASN A  22      -39.96   -133.91                                   
REMARK 500 12 PHE A  23      102.58    -51.22                                   
REMARK 500 13 ASN A   3       18.21   -144.36                                   
REMARK 500 13 CYS A   7      -43.37   -131.19                                   
REMARK 500 13 HIS A  18       22.50   -149.04                                   
REMARK 500 13 SER A  28       67.81   -117.41                                   
REMARK 500 13 THR A  36       38.04    -81.82                                   
REMARK 500                                                                      
REMARK 500 THIS ENTRY HAS      78 RAMACHANDRAN OUTLIERS.                        
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 34069   RELATED DB: BMRB                                 
REMARK 900 SOLUTION STRUCTURE OF OXIDIZED AND AMIDATED HUMAN IAPP (1-37), THE   
REMARK 900 DIABETES II PEPTIDE.                                                 
DBREF  5MGQ A    1    37  UNP    P10997   IAPP_HUMAN      34     70             
SEQRES   1 A   37  LYS CYS ASN THR ALA THR CYS ALA THR GLN ARG LEU ALA          
SEQRES   2 A   37  ASN PHE LEU VAL HIS SER SER ASN ASN PHE GLY ALA ILE          
SEQRES   3 A   37  LEU SER SER THR ASN VAL GLY SER ASN THR TYC                  
MODRES 5MGQ TYC A   37  TYR  MODIFIED RESIDUE                                   
HET    TYC  A  37      24                                                       
HETNAM     TYC L-TYROSINAMIDE                                                   
FORMUL   1  TYC    C9 H12 N2 O2                                                 
HELIX    1 AA1 CYS A    7  LEU A   16  1                                  10    
SSBOND   1 CYS A    2    CYS A    7                          1555   1555  2.02  
LINK         C   THR A  36                 N   TYC A  37     1555   1555  1.31  
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
MODEL        1